For decades, one of the strongest weapons against malaria has been a one-two punch: low-tech mosquito bed nets to physically block biting, treated with deadly insecticides to kill the mosquitoes.
With widespread use of this combination, malaria deaths have dropped significantly -- though nearly 445,000 people died from the disease in 2016 alone. But now the threat is again worsening, as the ever-adaptable pest has become resistant to insecticides.
Researchers found that they could use the same drug -- atovaquone -- used to treat the malaria parasite when a person gets sick, coat mosquito bed nets with it, and let mosquitoes ingest the anti-malarial drug. The medication "cures" the mosquito, so it can't spread the disease.
How did they get the medicine into the mosquitoes? The researchers developed computer models that explored how adding atovaquone to the bed nets and its ability to cure individual mosquitoes affected malaria prevalence in the human population as a whole. The' modeling factored in various external conditions, such as the current malaria prevalence, bed net coverage, and level of insecticide resistance.
They found that mosquitoes that sat on the surfaces for six minutes -- a typical resting time on bed nets -- would absorb the medicine needed to kill the malaria parasite in them. Similar transmission-blocking effects are achieved using other cytochrome b inhibitors, which demonstrates that parasite mitochondrial function is a suitable target for killing parasites. Incorporating these effects into a model of malaria transmission dynamics predicts that impregnating mosquito nets with Plasmodium inhibitors would substantially mitigate the global health effects of insecticide resistance.
The method could be more effective and less harmful to the people and environment in malaria hotspots. It has several advantages over the current techniques, the author said.
"The mosquito should not develop resistance to the compounds because we're just killing the parasite that's inside it," she said. "And atovaquone is already a licensed drug, so we know it's safe for humans."
https://vtnews.vt.edu/articles/2019/03/Science-malaria_control_atovaquone_netting.html
https://www.nature.com/articles/s41586-019-0973-1
Drug treated bed nets to slow malaria
- 1,089 views
- Added
Edited
Latest News
Gut bacteria may eliminate pathogens by competing for energy resources
How deep brain stimulation treats Parkinson's disease symptoms
Plasma membrane phospholipid plays a key role in epithelial cell adhesion
COVID-19, MIS-C and Kawasaki disease share same immune response
Improved cognition and mood by inducing neurogenesis via optogenetic stimulation of the brain
Other Top Stories
Researchers reveal type of vaginal bacteria that protects women from HIV
Antibiotic resistance in tuberculosis bacterium
An adaptor hierarchy regulates proteolysis during a bacterial cell cycle
Detecting HIV diagnostic antibodies with DNA nanomachines
Th17 cell induction by adhesion of microbes to intestinal epithelial cells
Protocols
Integrating neuroimaging and gene expression data using the imaging transcriptomics toolbox
Antibody structure prediction using interpretable deep learning
A semi-automated workflow for brain Slice Histology Alignment, Registration, and Cell Quantificat…
NanoDam identifies Homeobrain (ARX) and Scarecrow (NKX2.1) as conserved temporal factors in the D…
Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays
Publications
FMRP regulates GABAA receptor channel activity to control signal integration in hippocampal granu…
Host cells subdivide nutrient niches into discrete biogeographical microhabitats for gut microbes
Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury
Maturation of beta cells: lessons from in vivo and in vitro models
Plasma membrane phosphatidylinositol (4,5)-bisphosphate is critical for determination of epitheli…
Presentations
Hydrogels in Drug Delivery
Lipids
Cell biology of carbohydrate metabolism
RNA interference (RNAi)
RNA structure and functions
Posters
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE
ASCO-2020-GYNECOLOGIC CANCER